Enter to open, tab to navigate, enter to select
Techne Corporation acquisition of equity interests of Novus Biologicals
| July 02, 2014 • Private Acquisition Agreements • $60 million (subject to purchase price adjustment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.